Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

Scientists unveil plans to identify common social and cognitive elements in patients with Alzheimer’s disease, Depression, Schizophrenia

4th February 20206th March 2019
Scientists unveil plans to identify common social and cognitive elements in patients with Alzheimer’s disease, Depression, Schizophrenia - PRISM videos

6 March 2019: European scientists have mapped out a potentially radical new way to identify

PHAGO reveals complex role of TREM2 gene in Alzheimer’s disease

13th June 20228th January 2019

Scientists have shed new light on how a gene called TREM2 influences the progression of Alzheimer’s disease in different ways in the early and later stages.

The ROADMAP journey featured at Alzheimer Europe’s Conference – videos and presentations online!

4th February 20201st January 2019
ROADMAP data cube website

This included a plenary talk by Project Coordinator, John Gallacher, as well as four extensive parallel sessions on project achievements.

AETIONOMY final symposium and IMI neurodegeneration initiatives

4th February 202030th November 2018
AETIONOMY logo Organising Knowledge about Neurodegenerative Disease Mechanisms for the Improvement of Drug Development and Therapy

In December 2018, the AETIONOMY project reached the end of its funded period. The challenge

The European Prevention of Alzheimer’s Dementia Consortium passes the mark of 1,000 participants for its Longitudinal Cohort Study

5th February 202024th September 2018
The European Prevention of Alzheimer’s Dementia Consortium passes the mark of 1,000 participants for its Longitudinal Cohort Study

The EPAD Longitudinal Cohort Study has recruited its 1,000th participant at the University of Oxford (UK).

European Medical Information Framework reports on project success

4th February 202030th June 2018
EMIF European Medical Information Framework

EMIF has successfully improved access to human health data via providing tools and workflows to discover, assess, access and (re)use human health data.

AMYPAD diagnostic & patient management study recruits first participant

4th February 20204th May 2018
The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) Consortium AMYPAD alzheimer diagnostic

The members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) initiative proudly announced the recruitment of their first research participant.

Two IMPRiND researchers win Brain Prize!

4th February 20206th March 2018
Brain Prize Winners Michel Goedert Bart de Strooper IMPRiND Neuronet

The Brain Prize 2018 is awarded to Bart De Strooper, Michel Goedert, Christian Haass and

Post navigation
Newer posts
← Previous Page1 … Page28 Page29

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2023 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT